Akcea Therapeutics Inc. (AKCA)

Trade AKCA now with
6/5/2018 4:10:39 PM Akcea Therapeutics Appoints Richard Moscicki To Board Of Directors
6/5/2018 4:03:39 PM Ionis Pharmaceuticals Closes Strategic Collaboration With Biogen
6/1/2018 8:07:45 AM Akcea And Ionis Receive Positive EU CHMP Opinion For TEGSEDI
5/4/2018 7:04:02 AM Ionis Pharma Q1 Net Loss $10.8 Mln Vs Net Income Of $9.0 Mln Last Year
4/21/2018 12:54:12 PM Akcea Therapeutics To Present Data On Inotersen For The Treatment Of HATTR Amyloidosis
4/20/2018 6:31:52 AM Biogen And Ionis Expand Strategic Collaboration To Develop Drug Candidates For A Broad Range Of Neurological Diseases
4/17/2018 9:04:49 AM Akcea Therapeutics Says Sarah Boyce Joins As President
4/9/2018 7:02:18 AM Ionis Pharma Licensed IONIS-AZ6-2.5-LRx To AstraZeneca Following Advancement Of Drug Into Development
3/26/2018 7:08:10 AM Ionis, Akcea Present New Data From ATTR Amyloidosis Program At 16th International Symposium On Amyloidosis
3/15/2018 6:53:01 AM Ionis And Akcea Collaborate To Commercialize Inotersen For HATTR
2/27/2018 7:07:40 AM Ionis Pharma Q4 Revenue $172 Mln Vs $160 Mln Last Year